Cyclerion Therapeutics (CYCN) Competitor Comparison
We are evaluating the key criteria listed to compare Cyclerion Therapeutics (CYCN) against its competitors in the Biotechnology industry.
Market Capitalization
353 / 368Gross Profits
0 / 278Total Revenue
232 / 300EBITDA
125 / 337Free Cashflow
160 / 352Quick Ratio
225 / 357Earnings per Share
287 / 359Dividend yield
0 / 6Total Cash
325 / 358Performance 3 years
340 / 368Performance 5 years
306 / 368Performance 10 years
331 / 368Linearity 3 years
299 / 368Linearity 5 years
142 / 368Linearity 10 years
284 / 368Total Rank
307 / 368Dividend Rank
101 / 368Valuation Rank
200 / 368Piotroski Rank
353 / 368Muliplier Rank
324 / 368Dividend yield - CYCN ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.